Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma
- 1 July 2007
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 106 (1) , 82-88
- https://doi.org/10.1016/j.ygyno.2007.02.031
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum‐sensitive epithelial ovarian carcinomaCancer, 2006
- Temozolomide in uterine leiomyosarcomasGynecologic Oncology, 2005
- Secondary cytoreductive surgery for recurrent epithelial ovarian cancerPublished by Wolters Kluwer Health ,2002
- Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian CancerGynecologic Oncology, 2001
- Complete Salvage Surgical Cytoreduction Improves Further Survival of Patients with Late Recurrent Ovarian CancerGynecologic Oncology, 2000
- Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancerEuropean Journal of Surgical Oncology, 2000
- Prolonged Oral Etoposide in Recurrent or Advanced Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group StudyGynecologic Oncology, 1998
- Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective studyCancer, 1995
- Resection of pulmonary metastases from uterine sarcomasGynecologic Oncology, 1992
- FIGO NewsInternational Journal of Gynecology & Obstetrics, 1989